Pegevongitide

Approval Year

Name

Type

Language

N<sup>2.1<sup> -{3-[(2-{[?-(3-[?-(2-{[3-(L -histidyl-L-histidyl-L-histidyl-L-arginyl-L-histidyl-L-seryl-L-phenylalanin-N<sup>2.1<sup> -yl)-3-oxopropyl]sulfanyl}acetamido)poly(oxyethylene)-?-yl]-2,2-bis{[?-(2-{[3-(L-histidyl-L-histidyl-L-histidyl-L-arginy

Preferred Name

English

Pegevongitide

Official Name

English

pegevongitide [INN]

Common Name

English

Poly(oxy-1,2-ethanediyl), ?-hydro-?-hydroxy- (10K), ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1), 1,1?,1??,1???-tetraether with N-[3-[[2-[(2-hydroxyethyl)amino]-2-oxoethyl]thio]-1-oxopropyl]-L-histidyl-L-histidyl-L-histidyl-L-arginyl-L-histidy

Common Name

English

Code System Code Type Description

NCI_THESAURUS

C211765

Created by admin on Wed Apr 02 09:32:12 GMT 2025 , Edited by admin on Wed Apr 02 09:32:12 GMT 2025

PRIMARY

CAS

2988012-71-9

Created by admin on Wed Apr 02 09:32:12 GMT 2025 , Edited by admin on Wed Apr 02 09:32:12 GMT 2025

PRIMARY

FDA UNII

DB2XB649O5

Created by admin on Wed Apr 02 09:32:12 GMT 2025 , Edited by admin on Wed Apr 02 09:32:12 GMT 2025

PRIMARY

INN

13396

Created by admin on Wed Apr 02 09:32:12 GMT 2025 , Edited by admin on Wed Apr 02 09:32:12 GMT 2025

PRIMARY

ACTIVE MOIETY


					DB2XB649O5

Pegevongitide